SUPN - Supernus Pharmaceuticals Inc. (SUPN) CEO Jack Khattar on Q4 2020 Results - Earnings Call Transcript
Supernus Pharmaceuticals, Inc. (SUPN) Q4 2020 Earnings Conference Call February 25, 2021, 16:30 ET Company Participants Peter Vozzo - Westwicke Partners Jack Khattar - Founder, President, CEO, Secretary & Director James Kelly - EVP & CFO Conference Call Participants David Steinberg - Jefferies David Amsellem - Piper Sandler & Co. Nicholas Rubino - Stifel, Nicolaus & Company Presentation Operator Good afternoon, and welcome to Supernus Pharmaceuticals Fourth Quarter and Full Year 2020 Financial Results Conference Call. [Operator Instructions]. I would now like to turn the conference over to Peter Vozzo of Westwicke, Investor Relations representative for Supernus Pharmaceuticals. You may begin. Peter Vozzo Thank you, Alex. Good afternoon, everyone, and thank you for joining us today for Supernus Pharmaceuticals' Fourth Quarter and Full Year 2020 financial Results Conference Call. Today, after the close of the market, the company issued a press release announcing these results. On the call with me
For further details see:
Supernus Pharmaceuticals, Inc. (SUPN) CEO Jack Khattar on Q4 2020 Results - Earnings Call Transcript